PJP250117P89000
- 0.00
- 0.000.00%
Invesco Pharmaceuticals ETF Newsroom
Merck, Eisai Update On Phase 3 LEAP-015 Trial; At Interim Analysis, Keytruda Plus Lenvima-based Regimen Showed Statistically Significant Improvement In Progression-free Survival
Daily Options Tracking | MSTR Call ratio soared to 76%, a major investor bets nearly 80 million dollars on recent call orders; trading for Pfizer before earnings is hot, with one call order earning over twice the amount.
The options trading volume for cryptocurrency miner MARA was also hot yesterday, increasing by 74% compared to the previous trading day to 0.4 million contracts, with Calls accounting for 76%; on the Options Chain, the bullish forces were very strong, with the highest volumes of Call contracts at strike prices of $20 and $20.5, totaling 45,600 and 32,400 contracts respectively.
Allurion Stock Soars 70% on Weight-loss Therapy Update
Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings)
Why Is Abbott Stock Trading Higher On Thursday?
'Purdue Pharma's Sacklers Strike New $6.5 Billion Settlement of Opioid Claims' - WSJ
Congressional Trading Report: Rep. Thomas Kean Bought Over $1K In Abbott Laboratories Stock
RBC Capital Reiterates Outperform on Abbott Laboratories, Maintains $135 Price Target
BofA Adds Booz Allen Hamilton and Datadog to Its US 1 List
Abbott Shares Are Trading Higher After Multiple Analysts Raised Their Price Targets on the Stock.
UBS Strategist Andrew Garthwaite Says 6 Out of 7 Preconditions for a Bubble Met
Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $136
Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $165
AbbVie And Neomorph Announce Collaboration For Oncology And Immunology Drug Development, Featuring Molecular Glue Discovery Platform; Neomorph To Receive Upfront Payment Plus Up To $1.64B In Future Milestones.
Abbott Laboratories Analyst Ratings
Johnson & Johnson Analyst Ratings
Johnson & Johnson Reports Publication Of Findings From Nipocalimab Phase 3 Study In Broad Antibody Positive Population Of People With Generalized Myasthenia Gravis In The Lancet Neurology
S&P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In 'Fear' Zone
S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst